FCOMV
IRON icon

Foresite Capital Opportunity Management V’s Disc Medicine IRON Stock Holding History

Foresite Capital Opportunity Management V’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$3.99M Hold
81,171
– – 11.99% 3
2022
Q2 		$4.12M Hold
81,171
– – 10.37% 4
2022
Q1 		$3.38M Hold
81,171
– – 4.74% 7
2021
Q4 		$7.09M Buy
+81,171
New +$7.96M 4.75% 4

Other funds holding IRON

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $362M AUM 386.37% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Foresite Capital Opportunity Management V's IRON Position: Q3 2022 in Review

Foresite Capital Opportunity Management V held its Disc Medicine (IRON) position steady in Q3 2022 at 81,171 shares worth $3.99M. The position accounts for 11.99% of the portfolio, ranked #3.

Foresite Capital Opportunity Management V first reported a position in IRON in Q4 2021 and has held it in 4 quarters since. The position peaked at $7.09M in Q4 2021. 44 funds tracked by Wall St. Rank hold IRON as of Q3 2022.

  • Foresite Capital Opportunity Management V held 81,171 shares of Disc Medicine worth $3.99M as of Q3 2022.
  • Foresite Capital Opportunity Management V left its Disc Medicine share count unchanged in Q3 2022.
  • Disc Medicine made up 11.99% of Foresite Capital Opportunity Management V's portfolio in Q3 2022, its #3 holding.
  • Foresite Capital Opportunity Management V first reported a position in Disc Medicine in Q4 2021 and has held it in 4 quarters since.
  • Foresite Capital Opportunity Management V's Disc Medicine position peaked at $7.09M in Q4 2021.
  • 44 funds tracked by Wall St. Rank held Disc Medicine as of Q3 2022.

Based on Foresite Capital Opportunity Management V's 13F filing for Q3 2022, filed 14 Nov 2022.